ArticleJournal of pathology informatics2020
Deep Learning to Estimate Human Epidermal Growth Factor Receptor 2 Status from Hematoxylin and Eosin-Stained Breast Tissue Images.
Article in Journal of pathology informatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Transforming histologic assessment: artificial intelligence in cancer diagnosis and personalized treatment.British journal of cancer · 2025Pooled it
- Integrating Artificial Intelligence into Breast Cancer Histopathology: Toward Improved Diagnosis and Prognosis.Cancers · 2026Review
- Thyroid cancer detection and classification using spectral imaging and artificial intelligence.Scientific reports · 2026Article
- Mucin phenotype-based deep learning framework for intestinal metaplasia-carcinogenesis progression prediction.NPJ precision oncology · 2025Article
- AUPA: weakly supervised approach for streamlining breast cancer diagnostic workflow by WSI histological type classification for efficient IHC triage.Scientific reports · 2025Article
- Corr-A-Net: Interpretable Attention-Based Correlated Feature Learning framework for predicting of HER2 Score in Breast Cancer from H&E Images.medRxiv : the preprint server for health sciences · 2025Article
- Machine learning prediction of HER2-low expression in breast cancers based on hematoxylin-eosin-stained slides.Breast cancer research : BCR · 2025Article
- Deep learning model for detecting high-grade dysplasia in colorectal adenomas.Journal of pathology informatics · 2025Article
- Article
- Publicly available datasets of breast histopathology H&E whole-slide images: A scoping review.Journal of pathology informatics · 2024Article
- Artificial intelligence for human gunshot wound classification.Journal of pathology informatics · 2024Article
- Computational pathology in the identification of HER2-low breast cancer: Opportunities and challenges.Journal of pathology informatics · 2024Review
- Current status and prospects of artificial intelligence in breast cancer pathology: convolutional neural networks to prospective Vision Transformers.International journal of clinical oncology · 2024Review
- Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence.Cancers · 2024Review
- Breaking Barriers: AI's Influence on Pathology and Oncology in Resource-Scarce Medical Systems.Cancers · 2023Review
- Artificial Intelligence in Breast Cancer Diagnosis and Personalized Medicine.Journal of breast cancer · 2023Review
- Deep learning to automatically evaluate HER2 gene amplification status from fluorescence in situ hybridization images.Scientific reports · 2023Article
- Biological insights and novel biomarker discovery through deep learning approaches in breast cancer histopathology.NPJ breast cancer · 2023Review
- Breast Cancer Dataset, Classification and Detection Using Deep Learning.Healthcare (Basel, Switzerland) · 2022Review
- Strategies for Enhancing the Multi-Stage Classification Performances of HER2 Breast Cancer from Hematoxylin and Eosin Images.Diagnostics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextSeveral therapeutically important mutations in cancers are economically detected using immunohistochemistry (IHC), which highlights the overexpression of specific antigens associated with the mutation. However, IHC panels can be imprecise and relatively expensive in low-income settings. On the other hand, although hematoxylin and eosin (H&E) staining used to visualize the general tissue morphology is a routine and low cost, it does not highlight any specific antigen or mutation.
aimsUsing the human epidermal growth factor receptor 2 (HER2) mutation in breast cancer as an example, we strengthen the case for cost-effective detection and screening of overexpression of HER2 protein in H&E-stained tissue. SETTINGS AND
designWe use computational methods that reliably detect subtle morphological changes associated with the over-expression of mutation-specific proteins directly from H&E images. SUBJECTS AND
methodsWe trained a classification pipeline to determine HER2 overexpression status of H&E stained whole slide images. Our training dataset was derived from a single hospital containing 26 (11 HER2+ and 15 HER2-) cases. We tested the classification pipeline on 26 (8 HER2+ and 18 HER2-) held-out cases from the same hospital and 45 independent cases (23 HER2+ and 22 HER2-) from the TCGA-BRCA cohort. The pipeline was composed of a stain separation module and three deep neural network modules in tandem for robustness and interpretability. STATISTICAL ANALYSIS USED: We evaluate our trained model through area under the curve (AUC)-receiver operating characteristic.
resultsOur pipeline achieved an AUC of 0.82 (confidence interval [CI]: 0.65-0.98) on held-out cases and an AUC of 0.76 (CI: 0.61-0.89) on the independent dataset from TCGA. We also demonstrate the region-level correspondence of HER2 overexpression between a patient's IHC and H&E serial sections.
conclusionsOur work strengthens the case for automatically quantifying the overexpression of mutation-specific proteins in H&E-stained digital pathology, and it highlights the importance of multi-stage machine learning pipelines for added robustness and interpretability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.